| advertise add site services publishers database health videos | ![]() | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Valeant Pharma begins selling generic IBS drugThe Associated Press - Nov 23, 2009 Valeant Pharmaceuticals said Monday it began selling a generic version of Librax, a treatment for irritable bowel syndrome drug. Valeant said its product is ... Valeant Launching Generic Digestive Drug Orange County Business Journal Oceanside Pharmaceuticals Announces Launch of Librax(R) AG PR Newswire (press release) Lexicon says IBS drug met mid-stage study goalThe Associated Press - Nov 13, 2009 THE WOODLANDS, Texas — Lexicon Pharmaceuticals Inc. said Friday an irritable bowel syndrome drug candidate met its goals in a mid-stage clinical trial. ... IBS – what is it precisely? Malta Independent Online Lexicon Announces Positive Phase 2 Results of LX1031 in Non-Constipating ... PR Newswire (press release) Market Report -- In Play (SCMP)MSN Money - Nov 25, 2009 Overall, the data analyses demonstrated that, in these trials, lubiprostone achieved a statistically significant response in patients with IBS-C as compared ... Now, that's irritatingExpress Buzz - 22 hours ago Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder. Also called spastic colon, it is a functional bowel disorder characterised by ... PPD and Janssen Pharmaceutica Collaborate to Develop Compounds for Treatment ...WELT ONLINE - Nov 16, 2009 "The IBS-d market holds significant drug development potential because of the lack of approved products for this indication, and new antibiotics are needed ... PPD awarded $330m development contract with Janssen OutSourcing-Pharma.com PPD will take Belgian firm's drugs through Phase II Local Tech Wire Sucampo presents additional data on lubiprostone at Gastro 2009pharmabiz.com - 14 hours ago Overall, the data analyses demonstrated that, in these trials, lubiprostone achieved a statistically significant response in patients with IBS-C as compared ... Ironwood Receives $75M from Astellas for IBS DrugOneMedPlace (blog) - Nov 11, 2009 While it may not be fatal, irritable bowel syndrome (IBS) ranks high in discomfort and embarrassment. The chronic gastrointestinal disorder is characterized ... Astellas Enters Asian Licensing Agreement for Ironwood's Phase III IBS Therapy ... Genetic Engineering News (press release) Ironwood lands $75M Asian deal for linaclotide FierceBiotech Almirall announces a US$ 15 M equity investment in Ironwood Pharmaceuticals ... PharmaLive.com (press release) Probiotics Role in IBS DebatedNatural Products Industry Insider - Nov 23, 2009 Certain probiotics are backed by strong scientific evidence and recognized as effective and safe solutions to tackle IBS symptoms in patients. ... Survey places IBS Hyderabad at No. 3 under 'Excellent Business Schools' for IndiaMBAUniverse.com - Nov 25, 2009 IBS Hyderabad has been placed at No. 3 in the category of 'Excellent Business School' in India, in the recently released rankings of MBA schools by ... German Pharmaceutical Wholesaler Fiebig Goes Live With IBS PharmaBigNews.biz (press release) - Nov 20, 2009 Pharmaceutical wholesaler Leopold Fiebig has now fully implemented the IBS Pharma for its industry-specific, highly customized financial accounting ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests... Bernard von NotHaus (Liberty Dollar) Aubrey de Grey, PhD Dr. Amanuel Sima, MD Dr. Bard Levey, DDS Neal Adams Robin Scovill (director) Richard Diaz (author) Dr. Kaayla T. Daniel, CCN Chana de Wolf, (cryonics researcher) Dr. Mary Ruwart (author & scientist) Richard Diaz (author) Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |